Vor Biopharma Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -31.9% | -31.9% | -28.4% |
| FY2022 | -36.7% | -36.7% | -30.8% |
| FY2023 | -78.2% | -78.2% | -59.5% |
| FY2024 | -120.9% | -120.9% | -81.8% |
| FY2025 | 423.6% | 423.6% | -150.0% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -31.9% | -31.9% | -28.4% |
| FY2022 | -36.7% | -36.7% | -30.8% |
| FY2023 | -78.2% | -78.2% | -59.5% |
| FY2024 | -120.9% | -120.9% | -81.8% |
| FY2025 | 423.6% | 423.6% | -150.0% |